Physician
Neurology
Dr. William J. Jagust, MD
William Jagust is an expert in the field of Neurology. He studied medicine at Stony Brook University School of Medicine. William Jagust is a published doctor. He published 61 publications, including: 'Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.'
Publications
- Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease.
- Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes.
- GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.
- Improved power to characterize longitudinal amyloid-β PET changes and evaluate amyloid-modifying treatments using a cerebral white matter reference region.
- Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls.
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease.
- Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.
- The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function.
- Impaired prefrontal sleep spindle regulation of hippocampal-dependent learning in older adults.
- Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy.
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
- The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longit...
- Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability.
- The centiloid project: Standardizing quantitative amyloid plaque estimation by PET.
- Neural compensation in older people with brain amyloid-β deposition.
- Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease.
- Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.
- Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative.
- Gene-Environment Interactions: Lifetime Cognitive Activity, APOE Genotype, and Beta-Amyloid Burden.
- Time for tau.
- Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
- Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.
- Cortical thickness mediates the effect of β-amyloid on episodic memory.
- Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults.
- Dopamine and the Cognitive Downside of a Promised Bonus.
- Practical utility of amyloid and FDG-PET in an academic dementia center.
- Associations Between Serum Cholesterol Levels and Cerebral Amyloidosis.
- Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroim...
- Frontotemporal Network Connectivity during Memory Encoding Is Increased with Aging and Disrupted by Beta-Amyloid.
- Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry.
- Associations Between Alzheimer Disease Biomarkers, Neurodegeneration, and Cognition in Cognitively Normal Older People.
- Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism.
- The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
- Biomarkers and Brain Connectivity.
- Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
- Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease.
- Imaging markers for Alzheimer disease: Which vs how.
- Effect of Cognitive Reserve Markers on Alzheimer Pathologic Progression.
- Comparing PET imaging and CSF measurements of Aß
- Association of plasma and cortical amyloid beta is modulated by APOE ?4 status.
- The effect of amyloid ? on cognitive decline is modulated by neural integrity in cognitively normal elderly.
- APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.
- Association of Gray Matter Atrophy with Age, ?-Amyloid, and Cognition in Aging.
- A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations.
- Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
- Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-dependent memory in aging.
- Vulnerable neural systems and the borderland of brain aging and neurodegeneration.
- Amyloid-? imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods.
- Tracking brain amyloid-β in presymptomatic Alzheimer's disease.
- Covarying alterations in Aβ deposition, glucose metabolism, and gray matter volume in cognitively normal elderly.
- Factors affecting A? plasma levels and their utility as biomarkers in ADNI.
- Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
- Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.
- An inverse association of cardiovascular risk and frontal lobe glucose metabolism.
- Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
- Before it is too late: professional responsibilities in late-onset Alzheimer's research and pre-symptomatic prediction.
- Dorsal striatal dopamine, food preference and health perception in humans.
- Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
- Differences in prefrontal, limbic, and white matter lesion volumes according to cognitive status in elderly patients with first-onset subsyndromal depression.
- The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI).
Schools
State University of New York Health Science Center At Stony Brook
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
Boston University Medical Center -
St Elizabeth's Medical Center -
Stony Brook University School of Medicine
Helpful Reviews
Similar Doctors
|
Dr. Jennifer L. Ault, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane D. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ivan F. Diamond, MD |
|
|
Dr. Robert S. Janssen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert T. Knight, MD |
|
|
Dr. Selena W. Ellis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gail A. Kang, MD
This Doctor is OpenDoctor Recommended.
|